In addition, the activation of the NF-κB pathway mediated by the cytokines TNF-α and TGF-β1 is observed commonly in human and animal NASH models [13,15,16]. The gene discussed is NFKB1; the disease is metabolic dysfunction-associated steatohepatitis.